SUPPRESSION OF EXPRESSION OF GENE C-KIT IN CELLS OF NEUROBLASTOMA AND LENTIVIRAL CONSTRUCTIONS, DIRECTING SYNTHESIS SHPHK, SPECIFIC FOR GIVEN GENE Russian patent published in 2017 - IPC C12N15/113 C12N15/63 

Abstract RU 2609107 C1

FIELD: biotechnologies.

SUBSTANCE: recombinant genetic construction cloned into retroviral or lentiviral vector according to the sites restriction XpaI and XhoI and directed to the suppression of the expression of oncogene C-KIT in neuroblastoma cells, and the use of said construction for the regulation of C-KIT gene activity and its protein product are suggested. A recombinant genetic construction is a kit-2-sense strand (5'-p-aacgCGGTTGAATGTAAGGCTTActtcctgcaaTAAGCCTTACATTCAACCGTGtttttc-3'), kit-2-antisense strand (5'-p-tcgagaaaaaCACGGTTGAATGTAAGGCTTAttgcaggaagTAAGCCTTACATTCAACCGcgtt-3'). A recombinant genetic construction may be used to suppress the expression of gene C-KIT in neuroblastoma cells and regulation of C-KIT gene activity and its protein product.

EFFECT: downregulation of the expression of oncogene C-KIT when introducing it in neuroblastoma cells expressing C-KIT, and slowing the growth rate of cancer cells.

2 cl, 4 dwg, 2 ex

Similar patents RU2609107C1

Title Year Author Number
GENETIC CASSETTE CONTAINING CODON-OPTIMIZED NUCLEOTIDE SEQUENCES OF TRAIL, PTEN AND IFNβ-1 GENES, AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ONCOLOGIC DISEASES 2020
  • Chulpanova Darya Sergeevna
  • Soloveva Valeriya Vladimirovna
  • Rizvanov Albert Anatolevich
RU2757502C1
RECOMBINANT PLASMID DNA LENTI sgRNA(MS2)_zeo_Myc, PROVIDING ACTIVATION OF Myc GENE EXPRESSION IN HUMAN CELLS, METHOD OF OBTAINING HUMAN CELLS WITH STABLY INCREASED EXPRESSION OF Myc GENE AND MONOCLONAL HUMAN BREAST CANCER CELL LINE BT549_Myc WITH STABLY INCREASED EXPRESSION OF Myc GENE 2022
  • Pershina Aleksandra Gennadevna
  • Sukhinina Ekaterina Vladimirovna
  • Kozlova Polina Konstantinovna
  • Nevskaia Kseniia Vladimirovna
  • Efimova Lina Viktorovna
  • Litviakov Nikolai Vasilevich
RU2812975C1
RECOMBINANT PLASMID DNAS PX458D10A_MYC, PROVIDING MYC GENE KNOCKOUT IN HUMAN CELLS, METHOD OF PRODUCING HUMAN CELL LINE WITH MYC GENE KNOCKOUT AND HUMAN BREAST CANCER CELL LINE MDA-MB231_MYC WITH SUPPRESSED MYC GENE EXPRESSION 2022
  • Pershina Aleksandra Gennadevna
  • Sukhinina Ekaterina Vladimirovna
  • Kozlova Polina Konstantinovna
  • Nevskaia Kseniia Vladimirovna
  • Efimova Lina Viktorovna
  • Litviakov Nikolai Vasilevich
RU2818348C1
GENE-THERAPEUTIC DNA VECTOR BASED ON THE GENE-THERAPEUTIC DNA VECTOR VTvaf17, CARRYING THE TARGET GENE CFTR, OR NOS1, OR AQ1, OR AQ3, OR AQ5, FOR TREATING DISEASES ASSOCIATED WITH THE NEED TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, A METHOD FOR PRODUCING AND USING IT, ESCHERICHIA COLI SCS110-AF/VTvaf17-CFTR STRAIN, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-NOS1, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-AQ1, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-AQ3, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-AQ5, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2705252C1
GENE TRANSITION MEDIATED BY LENTIVIRAL VECTOR AND METHOD FOR USING THE GENES 2001
  • Staut Dzh. Timoti
  • Appukuttan Binoj
RU2288742C2
DOUBLE-STRANDED RNA CAPABLE OF REDUCING EXPRESSION OF MUTANT ALLELE C.607G>A OF HUMAN GNAO1 GENE 2022
  • Bardina Maryana Vladimirovna
  • Klementeva Nataliya Vladimirovna
  • Svetlova Ekaterina Antonovna
  • Lunev Evgenij Andreevich
RU2816137C1
NUCLEIC ACID HAVING ACTIVITY OF SHORT INTERFERING RNA, VECTOR CONTAINING THIS NUCLEIC ACID COUPLED OPERABLY WITH SEQUENCES OF TRANSCRIPTION REGULATION, AND METHOD OF THEIR APPLICATION FOR INHIBITION OF CELL PROLIFERATION OF HUMAN PANCREATIC ADENOCARCINOMA 2013
  • Svirshchevskaja Elena Viktorovna
  • Smirnova Evgenija Vladimirovna
  • Rjazantsev Dmitrij Jur'Evich
  • Zubkov Dmitrij Anatol'Evich
  • Bojko Anna Aleksandrovna
RU2532842C1
UNIVERSAL EPIGENOME REPRESSOR OF TRANSCRIPTION OF TARGET GENES IN HUMAN CELLS 2020
  • Dashinimaev Erdem Bairovich
  • Karpov Dmitrij Sergeevich
  • Abashkin Dmitrij Antonovich
  • Shakirova Kseniya Maratovna
  • Kurishev Artemij Olegovich
  • Kondratev Nikolaj Vitalevich
  • Golimbet Vera Evgenevna
RU2748997C1
GENE-THERAPEUTIC DNA VECTOR BASED ON THE GENE-THERAPEUTIC DNA VECTOR GDTT1_8NAS12, CARRYING THE TARGET GENE SELECTED FROM A GROUP OF GENES DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, IL2 TO INCREASE THE EXPRESSION LEVEL OF SAID TARGET GENES, A METHOD FOR PRODUCTION AND USE THEREOF, A STRAIN ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-DDC OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL10 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL13 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IFNB1 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-TNFRSF4 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-TNFSF10 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-BCL2 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-HGF OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL2, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2020
  • Gamolski Anton
RU2734726C1
PLASMID FOR REVEALING EPITHELIAL STATE OF HUMAN CELL 2019
  • Alekseev Boris Yakovlevich
  • Shkurnikov Maksim Yurevich
RU2716054C1

RU 2 609 107 C1

Authors

Spirin Pavel Vladimirovich

Lebedev Timofej Dmitrievich

Prasolov Vladimir Sergeevich

Dates

2017-01-30Published

2015-12-16Filed